Breaking News Instant updates and real-time market news.

2020-11-29 14:43:10 MRNA Moderna $128.00 / +18.82 (+17.24%) 14:43 11/29/20 11/29 14:43 11/29/20 14:43	Moderna announces amendment to COVID vaccine supply agreement with U.K. Moderna announced a supply agreement with the U.K. government for an additional 2M doses of mRNA-1273, Moderna's vaccine candidate against COVID-19, to the United Kingdom beginning in March 2021. The U.K. government has now secured 7M doses of mRNA-1273. On November 16, Moderna announced that the independent, NIH-appointed Data Safety Monitoring Board for the Phase 3 study of mRNA-1273, its vaccine candidate against COVID-19, has informed Moderna that the trial has met the statistical criteria pre-specified in the study protocol for efficacy, with a vaccine efficacy of 94.5%. This study, known as the COVE study, enrolled more than 30,000 participants in the U.S. and is being conducted in collaboration with the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, and the Biomedical Advanced Research and Development Authority, part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services. On October 27, 2020, Moderna received confirmation that the Medicines and Healthcare products Regulatory Agency in the U.K. started the rolling review process of mRNA-1273. Moderna continues to scale up its global manufacturing to be able to deliver approximately 500M doses per year and possibly up to 1B doses per year, beginning in 2021.	12 Feb 19 May
MRNA Moderna $128.00 / +18.82 (+17.24%) 11/27/20 Argus AstraZeneca's COVID vaccine faces high bar for FDA authorization, says Argus 11/25/20 Goldman Sachs Moderna price target raised to $139 from $107 at Goldman Sachs 11/23/20 Fly Intel: Top five analyst initiations 11/23/20 Wells Fargo Moderna initiated with an Equal Weight at Wells Fargo

2020-11-29 14:43:10

MRNA

Moderna

$128.00 / +18.82 (+17.24%)

14:43

11/29/20

11/29

14:43

11/29/20

14:43

Moderna announces amendment to COVID vaccine supply agreement with U.K.

Moderna announced a supply agreement with the U.K. government for an additional 2M doses of mRNA-1273, Moderna's vaccine candidate against COVID-19, to the United Kingdom beginning in March 2021. The U.K. government has now secured 7M doses of mRNA-1273. On November 16, Moderna announced that the independent, NIH-appointed Data Safety Monitoring Board for the Phase 3 study of mRNA-1273, its vaccine candidate against COVID-19, has informed Moderna that the trial has met the statistical criteria pre-specified in the study protocol for efficacy, with a vaccine efficacy of 94.5%. This study, known as the COVE study, enrolled more than 30,000 participants in the U.S. and is being conducted in collaboration with the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, and the Biomedical Advanced Research and Development Authority, part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services. On October 27, 2020, Moderna received confirmation that the Medicines and Healthcare products Regulatory Agency in the U.K. started the rolling review process of mRNA-1273. Moderna continues to scale up its global manufacturing to be able to deliver approximately 500M doses per year and possibly up to 1B doses per year, beginning in 2021.

12
Feb
19
May

MRNA Moderna

$128.00 / +18.82 (+17.24%)

11/27/20 Argus: AstraZeneca's COVID vaccine faces high bar for FDA authorization, says Argus

11/25/20 Goldman Sachs: Moderna price target raised to $139 from $107 at Goldman Sachs

11/23/20: Fly Intel: Top five analyst initiations

11/23/20 Wells Fargo: Moderna initiated with an Equal Weight at Wells Fargo

TODAY'S FREE FLY STORIES

Periodicals	EU seeks info from advertisers about Google's ad tech practices, Reuters says » 11:52 01/20/21 01/20 11:52 01/20/21 11:52 GOOG Alphabet $1,876.85 / +86.37 (+4.82%) , GOOGL Alphabet Class A $1,872.00 / +88.85 (+4.98%) European Union antitrust… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options GOOG GOOGL GOOG Alphabet $1,876.85 / +86.37 (+4.82%) 01/19/21 Google Cloud launches Product Discovery Solutions for Retail 01/17/21 Fly Intel: Top five weekend stock stories 01/14/21 Google completes acquisition of Fitbit, commits to protect users' privacy 01/14/21 Abbott launches NeuroSphere myPath digital health app GOOGL Alphabet Class A $1,872.00 / +88.85 (+4.98%) 01/19/21 Google Cloud launches Product Discovery Solutions for Retail 01/17/21 Fly Intel: Top five weekend stock stories 01/14/21 Google completes acquisition of Fitbit, commits to protect users' privacy 01/14/21 Abbott launches NeuroSphere myPath digital health app GOOG GOOGL GOOG Alphabet $1,876.85 / +86.37 (+4.82%) 01/19/21 JPMorgan JPMorgan says buy 'FANG' stocks amid 'fatigue and frustration' 01/15/21 MoffettNathanson Alphabet price target raised to $2,100 from $1,900 at MoffettNathanson 01/12/21 Cowen Alphabet price target raised to $2200 from $1900 at Cowen 01/11/21 Jefferies Yelp downgraded to Hold on 'full' valuation at Jefferies GOOGL Alphabet Class A $1,872.00 / +88.85 (+4.98%) 01/19/21 JPMorgan JPMorgan says buy 'FANG' stocks amid 'fatigue and frustration' 01/19/21 KeyBanc Alphabet price target to $2,060 from $1,970 at KeyBanc 01/15/21 MoffettNathanson Alphabet price target raised to $2,100 from $1,900 at MoffettNathanson 01/11/21 Jefferies Yelp downgraded to Hold on 'full' valuation at Jefferies GOOG GOOGL GOOG Alphabet $1,876.85 / +86.37 (+4.82%) 10/29/20 Alphabet reports Q3 Traffic Acquisition Costs $8.17B vs. $7.49B a year ago 10/29/20 Alphabet reports Q3 Google Cloud revenue $3.44B vs. $2.38B a year ago 10/29/20 Alphabet reports Q3 Google advertising revenue $37.1B vs. $33.8B a year ago 10/29/20 Alphabet reports Q3 EPS $16.40, consensus $11.29 GOOGL Alphabet Class A $1,872.00 / +88.85 (+4.98%) 10/29/20 Alphabet CFO sees signs user behavior beginning to return to normalized level 10/29/20 Alphabet reports Q3 Traffic Acquisition Costs $8.17B vs. $7.49B a year ago 10/29/20 Alphabet reports Q3 Google Cloud revenue $3.44B vs. $2.38B a year ago 10/29/20 Alphabet reports Q3 Google advertising revenue $37.1B vs. $33.8B a year ago GOOG GOOGL GOOG Alphabet $1,876.85 / +86.37 (+4.82%) 06:05 Today Google probes actions of ethical AI leader Margaret Mitchell, Axios reports 01/19/21 YouTube extends Trump channel ban for extra week, CNBC says 01/17/21 Google might face 4th government suit over business practices, Reuters says 01/14/21 Apple pulls social media platform Wimkin from App Store, WSJ reports GOOGL Alphabet Class A $1,872.00 / +88.85 (+4.98%) 06:05 Today Google probes actions of ethical AI leader Margaret Mitchell, Axios reports 01/19/21 YouTube extends Trump channel ban for extra week, CNBC says 01/17/21 Google might face 4th government suit over business practices, Reuters says 01/14/21 Apple pulls social media platform Wimkin from App Store, WSJ reports GOOG GOOGL GOOG Alphabet $1,876.85 / +86.37 (+4.82%) 01/11/21 Twitter seen at more risk than Facebook from Trump bans 12/22/20 FuboTV jumps as analysts up targets on 'strong upside momentum' 12/22/20 Fly Intel: Pre-market Movers 10/30/20 Fly Intel: Pre-market Movers GOOGL Alphabet Class A $1,872.00 / +88.85 (+4.98%) 01/11/21 Twitter seen at more risk than Facebook from Trump bans 12/22/20 FuboTV jumps as analysts up targets on 'strong upside momentum' 12/22/20 Fly Intel: Pre-market Movers 10/30/20 Fly Intel: Pre-market Movers 02/02/21 Alphabet Class A - GOOGL 02/02/21 Alphabet - GOOG GOOG GOOGL GOOG Alphabet $1,876.85 / +86.37 (+4.82%) 11/10/20 Alphabet call volume above normal and directionally bullish 10/30/20 Early notable gainers among liquid option names on October 30th GOOGL Alphabet Class A $1,872.00 / +88.85 (+4.98%) 09:55 Today Early notable gainers among liquid option names on January 20th 10/30/20 Early notable gainers among liquid option names on October 30th 10/21/20 Unusually active option classes on open October 21st 08/27/20 Alphabet Class A call volume above normal and directionally bullish
Periodicals	State Street to eliminate 1,200 positions this year, BI reports » 11:47 01/20/21 01/20 11:47 01/20/21 11:47 STT State Street $77.70 / -0.82 (-1.04%) State Street Corp. is… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events STT State Street $77.70 / -0.82 (-1.04%) 01/19/21 State Street sees Q1 NII down about 68% sequentially 01/19/21 State Street sees Q1 fee revenue down y/y by low single digits 01/19/21 State Street board reinitiates share repurchase program of up to $475M in Q1 01/19/21 State Street faced 'a number of unprecedented challenges' in 2020 STT State Street $77.70 / -0.82 (-1.04%) 06:43 Today RBC Capital State Street price target raised to $86 from $78 at RBC Capital 01/11/21 Piper Sandler State Street price target raised to $81 from $69 at Piper Sandler 01/05/21 Wolfe Research State Street downgraded to Underperform from Peer Perform at Wolfe Research 01/05/21 Goldman Sachs State Street downgraded to Neutral from Buy at Goldman Sachs STT State Street $77.70 / -0.82 (-1.04%) 01/19/21 State Street reports Q4 EPS $1.39, consensus $1.56 10/16/20 State Street reports Q3 EPS $1.45, consensus $1.41 10/15/20 Notable companies reporting before tomorrow's open 10/15/20 Notable companies reporting before tomorrow's open STT State Street $77.70 / -0.82 (-1.04%) 12/11/20 State Street weighs strategic options for asset management unit, Bloomberg says 12/11/20 State Street weighs strategic options for asset management unit, Bloomberg says STT State Street $77.70 / -0.82 (-1.04%) 10/16/20 Fly Intel: Pre-market Movers 02/24/21 22nd Annual Virtual Financial Services Forum
Options	Spirit Airlines call volume above normal and directionally bullish » 11:45 01/20/21 01/20 11:45 01/20/21 11:45 SAVE Spirit Airlines $27.29 / +0.605 (+2.27%) Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Options SAVE Spirit Airlines $27.29 / +0.605 (+2.27%) 10/29/20 Spirit 'not ready' to make a call on what will happen with A319s near-term 10/29/20 Spirit Airlines sees potential to resume growth in mid-2021 10/29/20 Spirit Airlines plans to keep fleet of 31 A319s parked into 2021 10/29/20 Spirit Airlines sees FY21 CapEx about $100M-$125M SAVE Spirit Airlines $27.29 / +0.605 (+2.27%) 01/14/21 Susquehanna Spirit Airlines price target raised to $22 from $19 at Susquehanna 01/08/21 BofA Spirit Airlines upgraded to Neutral from Underperform at BofA 12/23/20 Citi Airline demand in early 2021 'looks soft,' says Citi 12/16/20 Fly Intel: Top five analyst downgrades SAVE Spirit Airlines $27.29 / +0.605 (+2.27%) 10/29/20 Spirit Airlines sees total Q4 revenue down 43%-45% y/y, consensus $453.93M 10/28/20 Spirit Airlines reports Q3 EPS ($1.07), consensus ($2.72) 10/28/20 Notable companies reporting after market close 07/22/20 Spirit Airlines reports Q2 adj. EPS ($3.59), consensus ($2.66) 08 May SAVE Spirit Airlines $27.29 / +0.605 (+2.27%) 01/18/21 Biden to block Trump's plan to lift COVID travel restrictions, Reuters reports 01/18/21 Trump lifting COVID travel restrictions on Europe/Brazil, Reuters reports 01/15/21 U.K. tightens borders to prevent arrival of new COVID strains, Reuters says 01/12/21 U.S. to expand proof of no COVID rule to all international visitors, WSJ says SAVE Spirit Airlines $27.29 / +0.605 (+2.27%) 10/28/20 Fly Intel: After-Hours Movers SAVE Spirit Airlines $27.29 / +0.605 (+2.27%) 01/14/21 Spirit Airlines call volume above normal and directionally bullish 11/16/20 Unusually active option classes on open November 16th 11/05/20 Spirit Airlines call volume above normal and directionally bullish 10/20/20 Spirit Airlines call volume above normal and directionally bullish
Recommendations	LafargeHolcim price target raised to CHF 57 from CHF 48 at UBS » 11:39 01/20/21 01/20 11:39 01/20/21 11:39 HCMLY LafargeHolcim $0.00 / + (+0.00%) UBS analyst Gregor… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Periodicals HCMLY LafargeHolcim $0.00 / + (+0.00%) 01/14/21 Berenberg LafargeHolcim initiated with a Hold at Berenberg 01/08/21 JPMorgan LafargeHolcim price target raised to CHF 59 from CHF 51 at JPMorgan 12/07/20 Jefferies LafargeHolcim initiated with a Hold at Jefferies 11/18/20 Deutsche Bank LafargeHolcim initiated with a Buy at Deutsche Bank HCMLY LafargeHolcim $0.00 / + (+0.00%) 01/04/21 LafargeHolcim in talks to acquire Bridgestone unit, Bloomberg says
Recommendations	HeidelbergCement price target raised to EUR 71.50 from EUR 68.50 at UBS » 11:38 01/20/21 01/20 11:38 01/20/21 11:38 HDELY HeidelbergCement $0.00 / + (+0.00%) UBS analyst Gregor… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research HDELY HeidelbergCement $0.00 / + (+0.00%) 01/14/21 Berenberg HeidelbergCement initiated with a Buy at Berenberg 01/08/21 JPMorgan HeidelbergCement price target raised to EUR 70 from EUR 60 at JPMorgan 01/06/21 Societe Generale HeidelbergCement upgraded to Buy from Hold at Societe Generale 12/16/20 Credit Suisse HeidelbergCement price target raised to EUR 69 from EUR 60 at Credit Suisse

Recommendations	GlaxoSmithKline price target raised to 1,450 GBp from 1,440 GBp at UBS » 11:38 01/20/21 01/20 11:38 01/20/21 11:38 GSK GlaxoSmithKline $37.81 / -0.72 (-1.87%) UBS analyst Laura… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options GSK GlaxoSmithKline $37.81 / -0.72 (-1.87%) 01/12/21 Vir Biotechnology, GlaxoSmithKline to evaluate VIR-7832 in COVID-19 patients 01/11/21 Eligo Bioscience enters research, option agreement with GlaxoSmithKline 12/21/20 Ligand, GSK in pact 'leveraging' Icagen's small molecule 'expertise' 12/17/20 Hikma Pharmaceuticals launches generic Advair Diskus following FDA approval GSK GlaxoSmithKline $37.81 / -0.72 (-1.87%) 09:56 Today Fly Intel: Top five analyst downgrades 06:32 Today Credit Suisse GlaxoSmithKline downgraded to Underperform from Neutral at Credit Suisse 05:29 Today Credit Suisse GlaxoSmithKline downgraded to Underperform from Neutral at Credit Suisse 01/15/21 Deutsche Bank GlaxoSmithKline initiated with a Hold at Deutsche Bank GSK GlaxoSmithKline $37.81 / -0.72 (-1.87%) 10/28/20 GlaxoSmithKline now sees 2020 adjusted EPS at lower end of down 1%-4% range 10/28/20 GlaxoSmithKline reports Q3 adjusted EPS 35.6p vs. 38.6p a year ago 10/08/20 GlaxoSmithKline sees impact of foreign exchange on Q3 sales of about 5% 07/29/20 GlaxoSmithKline reports Q2 adjusted EPS 19.2p, down 37% AER GSK GlaxoSmithKline $37.81 / -0.72 (-1.87%) 01/12/21 GSK looks to double blockbusters in portfolio by 2026, Bloomberg says 12/31/20 Drugmakers to hike U.S. prices on over 200 drugs, Reuters reports 12/23/20 Judge rules against White House drug pricing rule, Reuters says 12/11/20 GlaxoSmithKline offered $120 per share for Eidos Therapeutics, Bloomberg says GSK GlaxoSmithKline $37.81 / -0.72 (-1.87%) 09/08/20 Moderna slides as analyst says sell on rising COVID vaccine competition 03/03/21 2021 London Global Healthcare Virtual Conference 02/03/21 GlaxoSmithKline - GSK GSK GlaxoSmithKline $37.81 / -0.72 (-1.87%) 09/04/20 GlaxoSmithKline call volume above normal and directionally bullish 08/03/20 Unusually active option classes on open August 3rd 07/31/20 Unusually active option classes on open July 31st
Hot Stocks	First Eagle Alternative Credit COO, CFO Terry Olson to retire » 11:38 01/20/21 01/20 11:38 01/20/21 11:38 FCRD First Eagle Alternative Capital $3.70 / +0.03 (+0.82%) First Eagle Alternative… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News FCRD First Eagle Alternative Capital $3.70 / +0.03 (+0.82%) 11/16/20 Omega takes Alphabet Class A stake, exits position in JPMorgan
Recommendations	Ferguson price target raised to 10,050 GBp from 9,450 GBp at UBS » 11:37 01/20/21 01/20 11:37 01/20/21 11:37 FERGY Ferguson $0.00 / + (+0.00%) UBS analyst Gregor… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research FERGY Ferguson $0.00 / + (+0.00%) 01/14/21 Berenberg Ferguson downgraded to Sell from Hold at Berenberg 01/05/21 UBS Ferguson U.K. sale not that material, says UBS 01/05/21 RBC Capital Ferguson forecasts adjusted at RBC Capital 12/09/20 Barclays Ferguson price target raised to 9,000 GBp from 8,000 GBp at Barclays
Recommendations	CRH price target raised to 3,600 GBp from 3,450 GBp at UBS » 11:37 01/20/21 01/20 11:37 01/20/21 11:37 CRH CRH $44.88 / -0.12 (-0.27%) UBS analyst Gregor… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals CRH CRH $44.88 / -0.12 (-0.27%) 09/21/20 Ash Grove to upgrade import terminal in Florida CRH CRH $44.88 / -0.12 (-0.27%) 01/14/21 Berenberg CRH initiated with a Hold at Berenberg 01/08/21 JPMorgan CRH price target raised to EUR 41 from EUR 40 at JPMorgan 01/06/21 Societe Generale CRH upgraded to Buy on apparent Democratic majority at Societe Generale 01/06/21 Societe Generale CRH upgraded to Buy from Hold at Societe Generale CRH CRH $44.88 / -0.12 (-0.27%) 12/23/20 HeidelbergCement working to sell California operations, Bloomberg reports
Recommendations	Bankinter price target raised to EUR 4.60 from EUR 3.45 at UBS » 11:36 01/20/21 01/20 11:36 01/20/21 11:36 BKIMF Bankinter $0.00 / + (+0.00%) UBS analyst Ignacio… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research BKIMF Bankinter $0.00 / + (+0.00%) 12/14/20 JPMorgan Bankinter price target raised to EUR 3.60 from EUR 3.30 at JPMorgan 11/24/20 Morgan Stanley Bankinter price target raised to EUR 4.15 from EUR 3.90 at Morgan Stanley 10/23/20 Barclays Bankinter price target lowered to EUR 3.60 from EUR 3.80 at Barclays 10/23/20 UBS Bankinter price target lowered to EUR 3.45 from EUR 3.55 at UBS

Recommendations	Bankia price target raised to EUR 1.52 from EUR 1.09 at UBS » 11:36 01/20/21 01/20 11:36 01/20/21 11:36 BNKXF Bankia $0.00 / + (+0.00%) UBS analyst Ignacio… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals BNKXF Bankia $0.00 / + (+0.00%) 09/18/20 CaixaBank to acquire Bankia for exchange ratio of 0.6845 shares BNKXF Bankia $0.00 / + (+0.00%) 12/14/20 JPMorgan Bankia price target raised to EUR 1.20 from EUR 1.10 at JPMorgan 11/25/20 HSBC Bankia downgraded to Hold from Buy at HSBC 10/29/20 UBS Bankia price target lowered to EUR 1.09 from EUR 1.15 at UBS 10/20/20 UBS Bankia price target lowered to EUR 1.15 from EUR 1.30 at UBS BNKXF Bankia $0.00 / + (+0.00%) 09/17/20 Caixabank, Bankia boards approve merger agreement, Reuters reports 09/03/20 Bankia, Caixabank say they are considering merger, Bloomberg says
Periodicals	Tesla lowers Model 3 prices in Europe, Electrek reports » 11:35 01/20/21 01/20 11:35 01/20/21 11:35 TSLA Tesla $844.31 / -0.26 (-0.03%) Tesla has reduced Model 3… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options TSLA Tesla $844.31 / -0.26 (-0.03%) 01/19/21 EU passenger car registrations down 3.3% in December 01/14/21 Tesla director sells 10K shares of common stock 01/14/21 DPW Holdings subsidiary announces acceptance of pre-orders for EV charger 01/13/21 Tesla Model Y achieves 5-Star overall safety rating from NHTSA TSLA Tesla $844.31 / -0.26 (-0.03%) 09:16 Today JPMorgan JPMorgan boosts GM target to $63, calls 'significant contender' in autonomous 07:39 Today Deutsche Bank Tesla price target raised to $890 from $705 at Deutsche Bank 06:48 Today Oppenheimer Tesla price target raised to $1,036 from $486 at Oppenheimer 01/19/21 Jefferies Tesla price target raised to $775 from $650 at Jefferies TSLA Tesla $844.31 / -0.26 (-0.03%) 10/21/20 Tesla reports Q3 non-GAAP EPS 76c, consensus 56c 10/21/20 Notable companies reporting after market close 07/22/20 Tesla reports Q2 adjusted EPS 50c, consensus (11c) 07/22/20 Notable companies reporting after market close 14 Feb TSLA Tesla $844.31 / -0.26 (-0.03%) 01/19/21 Amazon and Ford backed EV Truck-maker Rivian raises another $2.65B, WSJ says 01/19/21 Tesla asks NHTSA to declare display issue 'inconsequential,' Reuters reports 01/18/21 Tesla says Model Y deliveries in China have officially begun 01/13/21 NHTSA asks Tesla to recall 158,000 cars over faulty touchscreens, Reuters says TSLA Tesla $844.31 / -0.26 (-0.03%) 01/14/21 Fly Intel: Pre-market Movers 01/11/21 NIO jumps after unveiling new luxury sedan to rival Tesla 01/08/21 Fly Intel: Pre-market Movers 01/06/21 Fly Intel: Pre-market Movers 01/27/21 Tesla - TSLA TSLA Tesla $844.31 / -0.26 (-0.03%) 08:55 Today Notable open interest changes for January 20th 01/13/21 Notable open interest changes for January 13th 01/12/21 Notable open interest changes for January 12th 01/11/21 Notable open interest changes for January 11th
Recommendations	Banco de Sabadell price target raised to EUR 0.40 from EUR 0.27 at UBS » 11:35 01/20/21 01/20 11:35 01/20/21 11:35 BNDSF Banco de Sabadell $0.00 / + (+0.00%) UBS analyst Ignacio… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Periodicals BNDSF Banco de Sabadell $0.00 / + (+0.00%) 11/27/20 Keefe Bruyette Sabadell downgraded to Underperform from Market Perform at Keefe Bruyette 11/05/20 UBS Banco de Sabadell price target lowered to EUR 0.27 from EUR 0.28 at UBS 11/03/20 Deutsche Bank Banco de Sabadell price target raised to EUR 0.45 at Deutsche Bank 10/20/20 UBS Banco de Sabadell price target lowered to EUR 0.28 from EUR 0.30 at UBS BNDSF Banco de Sabadell $0.00 / + (+0.00%) 09/08/20 Sabadell exploring strategic options, Bloomberg reports
Recommendations	Bayer price target raised to EUR 55 from EUR 47 at Credit Suisse » 11:33 01/20/21 01/20 11:33 01/20/21 11:33 BAYRY Bayer $0.00 / + (+0.00%) Credit Suisse analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events BAYRY Bayer $0.00 / + (+0.00%) 01/08/21 Argenx expects 2021 cash burn 'approximately doubling' compared to 2020 01/08/21 Bayer says FDA approves addition of OS and other data to Nubeqa prescribing info 01/07/21 Bayer signs collaboration, services agreement with CureVac for COVID-19 vaccine 12/22/20 Bayer, Veracyte announce new collaboration to advance precision oncology BAYRY Bayer $0.00 / + (+0.00%) 01/08/21 Morgan Stanley Bayer price target lowered to EUR 66 from EUR 67 at Morgan Stanley 01/07/21 Morgan Stanley CureVac COVID-19 deal provides 'sentiment boost' for Bayer, says Morgan Stanley 12/07/20 Stifel Atara Biotherapeutics price target raised to $33 from $28 at Stifel 12/07/20 Roth Capital Bayer collaboration a testament to Atara's T-cell prowess, says Roth Capital BAYRY Bayer $0.00 / + (+0.00%) 11/03/20 Bayer confirms FY20 targets, sees core EPS EUR6.70-EUR6.90 11/03/20 Bayer reports Q3 core EPS down 30.2% to EUR0.81 09/30/20 Bayer confirms 2020 adjusted view, sees 2021 core EPS 'slightly' down from 2020 09/30/20 Bayer expects 2021 sales at approximately 2020 levels BAYRY Bayer $0.00 / + (+0.00%) 01/06/21 CureVac, Bayer reach alliance deal over COVID-19 vaccine, Reuters says 10/27/20 EPA clears use of Bayer's XtendiMax for five years, Reuters reports 10/11/20 Bayer, BASF fighting to keep weedkiller on U.S. farms, WSJ reports 09/15/20 Bayer resolves thousands of U.S. Roundup cases with trial lawyers, Reuters says BAYRY Bayer $0.00 / + (+0.00%) 01/07/21 Fly Intel: Pre-market Movers 00:00 Today PDUFA Date for Vericiguat
Recommendations	Grifols price target lowered to EUR 26 from EUR 27 at Credit Suisse » 11:32 01/20/21 01/20 11:32 01/20/21 11:32 GRFS Grifols $19.38 / -0.4 (-2.02%) Credit Suisse analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals On The Fly GRFS Grifols $19.38 / -0.4 (-2.02%) 01/18/21 Grifols to begin clinical trial in Spain for new COVID-19 drug 11/13/20 Soros takes stake in Palantir, exits TransDigm position 11/09/20 Grifols acquires remaining 49% of Goetech for $60.2M 10/09/20 Grifols begins anti-SARS-CoV-2 hyperimmune globulin trial GRFS Grifols $19.38 / -0.4 (-2.02%) 01/13/21 Morgan Stanley Grifols price target lowered to EUR 31 from EUR 32 at Morgan Stanley 12/09/20 Morgan Stanley Grifols price target raised to EUR 32 from EUR 31 at Morgan Stanley 11/06/20 Morgan Stanley Grifols price target raised to EUR 31 from EUR 30 at Morgan Stanley 10/30/20 Berenberg Grifols price target lowered to EUR 24.50 from EUR 25.30 at Berenberg GRFS Grifols $19.38 / -0.4 (-2.02%) 09/01/20 NIH says not enough evidence to recommend convalescent plasma, Bloomberg reports 09/01/20 NIH panel says data fail to back EUA for convalescent plasma, Bloomberg reports GRFS Grifols $19.38 / -0.4 (-2.02%) 08/24/20 Plasma producers spike after EUA issued for convalescent plasma to treat COVID 08/24/20 Fly Intel: Pre-market Movers

Recommendations	Orion Oyj price target raised to EUR 35 from EUR 30 at Credit Suisse » 11:32 01/20/21 01/20 11:32 01/20/21 11:32 ORINF Orion Oyj $0.00 / + (+0.00%) Credit Suisse analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
Recommendations	Ahold Delhaize price target lowered to EUR 24 from EUR 25 at Credit Suisse » 11:30 01/20/21 01/20 11:30 01/20/21 11:30 ADRNY Ahold Delhaize $0.00 / + (+0.00%) Credit Suisse analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research ADRNY Ahold Delhaize $0.00 / + (+0.00%) 11/18/20 Ahold Delhaize, Centerbridge Partners to buy FreshDirect, terms not disclosed ADRNY Ahold Delhaize $0.00 / + (+0.00%) 11/20/20 Stifel Ahold Delhaize upgraded to Hold from Sell at Stifel 11/10/20 Morgan Stanley Ahold Delhaize price target raised to EUR 25.40 from EUR 25 at Morgan Stanley 11/09/20 Credit Suisse Ahold Delhaize initiated with a Neutral at Credit Suisse 11/05/20 JPMorgan Ahold Delhaize price target lowered to EUR 22 from EUR 23 at JPMorgan
Recommendations	easyJet price target raised to 934 GBp from 840 GBp at Credit Suisse » 11:29 01/20/21 01/20 11:29 01/20/21 11:29 ESYJY easyJet $0.00 / + (+0.00%) Credit Suisse analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Periodicals ESYJY easyJet $0.00 / + (+0.00%) 12/31/20 Fly Intel: Top five analyst calls 12/31/20 Citi easyJet downgraded to Sell from Neutral at Citi 12/17/20 Morgan Stanley easyJet price target raised to 900 GBp from 800 GBp at Morgan Stanley 12/14/20 AlphaValue easyJet upgraded to Reduce from Sell at AlphaValue ESYJY easyJet $0.00 / + (+0.00%) 12/22/20 Germany extends U.K. travel ban to January 6, Sky News reports
Recommendations	KBC Group price target lowered to EUR 60 from EUR 61 at Deutsche Bank » 11:27 01/20/21 01/20 11:27 01/20/21 11:27 KBCSY KBC Group $0.00 / + (+0.00%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research KBCSY KBC Group $0.00 / + (+0.00%) 01/14/21 Morgan Stanley KBC Group price target raised to EUR 71 from EUR 67 at Morgan Stanley 01/11/21 Deutsche Bank KBC Group downgraded to Hold from Buy at Deutsche Bank 01/07/21 Credit Suisse KBC Group downgraded to Neutral from Outperform at Credit Suisse 01/07/21 Credit Suisse KBC Group downgraded to Neutral from Outperform at Credit Suisse
Recommendations	Carl Zeiss Meditec price target raised to EUR 140 from EUR 120 at Deutsche Bank » 11:26 01/20/21 01/20 11:26 01/20/21 11:26 CZMWY Carl Zeiss Meditec $0.00 / + (+0.00%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research CZMWY Carl Zeiss Meditec $0.00 / + (+0.00%) 10/07/20 Microsoft, Zeiss announce multi-year strategic partnership CZMWY Carl Zeiss Meditec $0.00 / + (+0.00%) 11/02/20 Deutsche Bank Carl Zeiss Meditec price target raised to EUR 120 from EUR 110 at Deutsche Bank 10/23/20 UBS Carl Zeiss Meditec downgraded to Neutral from Buy at UBS 07/17/20 Berenberg Carl Zeiss Meditec price target raised to EUR 87 from EUR 81 at Berenberg 07/16/20 Deutsche Bank Carl Zeiss Meditec price target lowered to EUR 110 at Deutsche Bank

Recommendations	AirBoss of America price target lowered to C$28 from C$31 at CIBC » 11:20 01/20/21 01/20 11:20 01/20/21 11:20 ABSSF AirBoss of America $0.00 / + (+0.00%) CIBC analyst Scott… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings ABSSF AirBoss of America $0.00 / + (+0.00%) 10/26/20 AirBoss of America acquires 100% ownership of Airboss Defense Group 10/05/20 AirBoss of America announces $22M in awards across ADG's survivability portfolio 09/28/20 AirBoss of America announces Husky long-term contract extension ABSSF AirBoss of America $0.00 / + (+0.00%) 01/14/21 Canaccord AirBoss of America price target lowered to C$27 from C$43 at Canaccord 12/18/20 TD Securities AirBoss of America price target lowered to C$29 from C$32 at TD Securities 11/12/20 Stifel AirBoss of America price target lowered to C$33 from C$34 at Stifel 11/12/20 TD Securities AirBoss of America price target raised to C$32 from C$31 at TD Securities ABSSF AirBoss of America $0.00 / + (+0.00%) 01/19/21 AirBoss of America sees 2020 revenue $498M-$503M
Options	Vertical call spread in energy ETF targets 26% return for 2021 » 11:20 01/20/21 01/20 11:20 01/20/21 11:20 XLE Energy Select Sector SPDR $43.50 / -0.12 (-0.28%) Vertical call spread in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Options Technical Analysis XLE Energy Select Sector SPDR $43.50 / -0.12 (-0.28%) 12/29/20 Alpha One Capital's Dan Niles likes JPMorgan, Oracle, Magna Intl, Gan Ltd in '21 08/05/20 Energy shares surge amid spike in natural gas, crude inventory drop XLE Energy Select Sector SPDR $43.50 / -0.12 (-0.28%) 07/06/20 Goldman Sachs Rattler Midstream downgraded to Neutral from Buy at Goldman Sachs XLE Energy Select Sector SPDR $43.50 / -0.12 (-0.28%) 01/08/21 Size call sale in Energy ETF likely closes December trade 12/14/20 Unusually active option classes on open December 14th XLE Energy Select Sector SPDR $43.50 / -0.12 (-0.28%) 08:25 Today Energy Select Sector SPDR: Pivot points 01/15/21 On The Fly: Weekly technical notes for S&P 500 01/15/21 Energy Select Sector SPDR: Pivot points 01/14/21 Energy Select Sector SPDR: Pivot points
Periodicals	Brookfield, KKR mull offers for $10B Aramco pipeline stake, Bloomberg says » 11:18 01/20/21 01/20 11:18 01/20/21 11:18 BAM Brookfield $38.51 / +0.18 (+0.47%) , KKR KKR $41.52 / +0.55 (+1.34%) , APO Apollo Global $48.08 / -0.1 (-0.21%) Brookfield Asset… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options BAM KKR APO BAM Brookfield $38.51 / +0.18 (+0.47%) 01/04/21 Brookfield Property establishes committee to review Brookfield proposal 01/04/21 Brookfield proposes to acquire remaining Brookfield Property units for $5.9B 12/30/20 JCPenney replacing CEO Jill Soltau, Stanley Shashoua stepping in for now 12/14/20 Blackstone unit BPPLS to acquire portfolio of lab properties for $3.45B KKR KKR $41.52 / +0.55 (+1.34%) 01/13/21 KKR closes first Asia real estate Fund at $1.7B 01/13/21 Fiserv, KKR called out as best ideas by Oakmark's Bill Nygren 01/12/21 KKR expands real estate industrial portfolio in Phoenix 01/11/21 KKR invests in music catalog of Ryan Tedder and OneRepublic APO Apollo Global $48.08 / -0.1 (-0.21%) 01/04/21 Takkion Holdings acquires Renew Energy; terms not disclosed 12/23/20 Apollo-led group to acquire 49.9% stake in AB InBev U.S. metal container plants 12/21/20 Apollo agrees to increase Great Canadian Gaming purchase price to C$45 per share 12/15/20 Cardtronics transaction indicates enterprise value of $2.3B, including net debt BAM KKR APO BAM Brookfield $38.51 / +0.18 (+0.47%) 01/05/21 JPMorgan Brookfield deal 'value accretive and multiple enhancing,' says JPMorgan 12/23/20 RBC Capital Brookfield assumed with an Outperform at RBC Capital 11/18/20 Fly Intel: Top five analyst initiations 11/18/20 Goldman Sachs Brookfield initiated with a Conviction Buy at Goldman Sachs KKR KKR $41.52 / +0.55 (+1.34%) 01/11/21 Citi Citi opens 'positive Catalyst Watches' on Invesco, Carlyle, KKR 11/11/20 Deutsche Bank KKR price target raised to $40 from $38 at Deutsche Bank 08/05/20 Citi Citi adds KKR to U.S. Focus List, ups price target to $47.50 07/09/20 Keefe Bruyette KKR price target raised to $41 from $34 at Keefe Bruyette APO Apollo Global $48.08 / -0.1 (-0.21%) 09:15 Today Truist Athene Holding price target raised to $55 from $48 at Truist 01/11/21 Wells Fargo Apollo Global price target raised to $55 from $50 at Wells Fargo 12/18/20 Deutsche Bank Apollo Global price target raised to $51 from $49 at Deutsche Bank 11/06/20 Fly Intel: Top five analyst upgrades BAM KKR APO BAM Brookfield $38.51 / +0.18 (+0.47%) 11/12/20 Brookfield reports Q3 EPS 10c, consensus 47c 08/13/20 Brookfield reports Q2 EPS (43c), consensus 39c KKR KKR $41.52 / +0.55 (+1.34%) 10/30/20 KKR reports Q3 EPS 48c, consensus 40c 08/04/20 KKR reports Q2 adjusted EPS 39c, consensus 36c 08/03/20 Notable companies reporting before tomorrow's open 08/03/20 Notable companies reporting before tomorrow's open APO Apollo Global $48.08 / -0.1 (-0.21%) 10/29/20 Apollo Global reports Q3 fee-related EPS 63c, consensus 49c 10/28/20 Notable companies reporting before tomorrow's open 10/28/20 Notable companies reporting before tomorrow's open 07/30/20 Apollo Global reports Q2 fee-related EPS 59c, consensus 48c 11 Nov BAM KKR APO BAM Brookfield $38.51 / +0.18 (+0.47%) 11/10/20 Brookfield seeks to enter secondary market for private assets, Bloomberg says 10/25/20 Blackstone to buy Simply Self storage for $1.2B, WSJ reports 10/22/20 JCPenney's new owners reject pension plan, Dallas Morning News reports 10/19/20 Brookfield investing $2B in biggest Indian property deal yet, Bloomberg says KKR KKR $41.52 / +0.55 (+1.34%) 01/13/21 KKR closes inaugural APAC real estate fund at $1.7B, Reuters says 11/19/20 Bain, KKR weigh offers for Hitachi Metals, Nikkei Asia reports 11/18/20 Epic, Spotify not impressed with Apple App Store policy update, CNBC says 11/05/20 'Fortnite' to be playable on iOS devices via Nvidia GeForce, BBC reports APO Apollo Global $48.08 / -0.1 (-0.21%) 01/08/21 NCR in talks to bid against Apollo for Cardtronics, WSJ reports 01/08/21 NCR in talks to bid against Apollo for Cardtronics, WSJ reports 12/11/20 Apollo, Blackstone in talks for Wells Fargo student loan book, Bloomberg says 12/11/20 Apollo, Blackstone in talks for Wells Fargo student loan book, Bloomberg says APO APO Apollo Global $48.08 / -0.1 (-0.21%) 09/25/20 Sports betting space gains after William Hill receives two takeover offers 09/25/20 Fly Intel: Pre-market Movers 09/24/20 SPACs under pressure as SEC chairman voices disclosure concerns 09/03/20 Tesla slides as investor trims stake, QuantumScape joins EV SPAC craze 02/24/21 22nd Annual Virtual Financial Services Forum 02/03/21 Apollo Global - APO 02/11/21 Brookfield - BAM APO APO Apollo Global $48.08 / -0.1 (-0.21%) 10/22/20 Apollo Global put volume heavy and directionally bearish
Syndicate	Oyster Enterprises Acquisition opens at $10.17, IPO priced at $10 per unit » 11:18 01/20/21 01/20 11:18 01/20/21 11:18 OSTR Oyster Enterprises Acquisition $0.00 / + (+0.00%) Oyster Enterprises… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
Technical Analysis	NASDAQ market internals summary » 11:17 01/20/21 01/20 11:17 01/20/21 11:17 $NSD NASDAQ Market Internals $0.00 / + (+0.00%) Volume is above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Technical Analysis $NSD NASDAQ Market Internals $0.00 / + (+0.00%) 10:17 Today NASDAQ market internals summary 01/19/21 NASDAQ market internals summary 01/19/21 NASDAQ market internals summary 01/19/21 NASDAQ market internals summary

Events

Earnings calls, analyst events, roadshows and more

Today at 12:00

Software & Internet Industry Meetings
Today at 13:00

Software & Internet Industry Meetings
Today at 14:00

Food/Agribusiness Industry Meetings
Today at 14:00

Energy Transition Industry Meetings
KMI
Today at 16:30

Kinder Morgan - KMI Conference Calls
AA
Today at 17:00

Alcoa - AA Conference Calls
HWC
Today at 17:00

Hancock Whitney - HWC Conference Calls
NVEC
Today at 17:00

NVE Corp. - NVEC Conference Calls
AGN ...
Tomorrow at 00:00

Aesthetics Tech Virtual Summit 2021 Conferences

Virtual Summit
Tomorrow at 00:00

2021 Conservation Finance Virtual Conference Conferences

Virtual Conference

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	TCRR X TCRR TCR2 Therapeutics Secondary Managers: Goldman Sachs, Jefferies, Piper Sandler & BMO Capital Priced at: $30.50 4.59M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ACRS X ACRS Aclaris Therapeutics Spot Secondary Managers: Cantor Fitzgerald & William Blair, H.C. Wainwright Priced at: $17.50 5.484M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ACRX X ACRX AcelRx Spot Secondary Managers: Cantor Fitzgerald Priced at: $1.90 14.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BLRX X BLRX BioLineRx Spot Secondary Managers: H.C. Wainwright Priced at: $2.40 12.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BNGO X BNGO Bionano Genomics Spot Secondary Managers: Oppenheimer, BTIG, Ladenburg, Maxim Priced at: $6.00 33.333M Shares DSS X DSS Document Security Spot Secondary Managers: Aegis Priced at: $3.60 6.67M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FULC X FULC Fulcrum Therapeutics Spot Secondary Managers: SVB Leerink, Piper Sandler & Credit Suisse Priced at: $11.00 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LAC X LAC Lithium Americas Spot Secondary Managers: Canaccord, Deutsche Bank, Evercore ISI, Stifel Priced at: $22.00 15.9M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PERI X PERI Perion Network Spot Secondary Managers: Oppenheimer, Stifel, Roth Capital, LAKE Priced at: $11.50 4.99M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SYRS X SYRS Syros Pharmaceuticals Spot Secondary Managers: Cowen & Piper Sandler Priced at: $14.00 5.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	BDGE X BDGE Bridge Bancorp Block Trade Managers: Morgan Stanley $25.50-26.50 700K Shares
Wed	DFH X DFH Dream Finders Homes IPO Managers: BofA, RBC Capital & BTIG, Builder Advisor, Zelman, TCB Capital, Wedbush $12.00-15.00 9.6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MYTE X MYTE Mytheresa IPO Managers: Morgan Stanley & JPMorgan, Credit Suisse, UBS, Jefferies, Cowen $24.00-26.00 15.647M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RLX X RLX RLX Technology IPO Managers: Citi, China Renaissance $8.00-10.00 116.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ATHA X ATHA Athira Pharma Secondary Managers: Goldman Sachs, Jefferies, Stifel & JMP Securities $26.55 4M Shares CDNA X CDNA CareDx Secondary Managers: Goldman Sachs & Jefferies, Raymond James, BTIG, Craig-Hallum, H.C. Wainwright $93.33 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CMRX X CMRX Chimerix Secondary Managers: Jefferies & Cowen, H.C. Wainwright, JonesTrading $8.10 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CTMX X CTMX CytomX Therapeutics Secondary Managers: JPMorgan, Cowen & Piper Sandler $8.48 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CYRX X CYRX Cryoport Secondary Managers: Morgan Stanley, Jefferies, SVB Leerink & UBS $76.12 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DYN X DYN Dyne Therapeutics Secondary Managers: JPMorgan, Jefferies, Piper Sandler & Stifel $28.61 5.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial EDIT X EDIT Editas Medicine Secondary Managers: JPMorgan & Morgan Stanley, Cowen, Credit Suisse $72.11 3.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MRUS X MRUS Merus Secondary Managers: Jefferies & SVB Leerink $24.71 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CYRX X CYRX Cryoport Spot Secondary Managers: Morgan Stanley, Jefferies, SVB Leerink & UBS $ Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	PAX X PAX Patria IPO Managers: JPMorgan, BofA & Credit Suisse, Goldman Sachs, Bradesco BBI, BTG Pactual, ITAU, Keefe Bruyette, Santander, XP $14.00-16.00 26.65M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AZEK X AZEK Azek Secondary Managers: Barclays, BofA, Goldman Sachs & Jefferies $42.25 17.5M Shares CRSR X CRSR Corsair Gaming Secondary Managers: Goldman Sachs, Barclays, Credit Suisse, Macquarie, Baird, Cowen, & Stifel, Wedbush, Academy Securities $37.73 7.5M Shares PASG X PASG Passage Bio Secondary Managers: JPMorgan, Goldman Sachs & Cowen, Wedbush, Chardan $29.05 7M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

View All Syndicate Announcements »

Moderna announces amendment to COVID vaccine supply agreement with U.K.

TODAY'S FREE FLY STORIES

Get Full Fly Access